Month: February 2020

Cancer Treatment: Tackling the Disease Through Innovative Strategies

Posted on by Admin

Cancer Treatment: Tackling the Disease Through Innovative Strategies

Current revolutionary new strategies to defeat cancer will be discussed by experts at the forefront of cancer research and treatment. The medical researchers and academic will probe into the most advanced new technologies aimed at overcoming cancer including innate immunity, modulation of tumor micro-environment, treatment of solid tumors with CAR-T, cancer vaccines and cell cycle inhibitors.

  • Dr. James Mule, Associate Center Director at Moffitt Cancer Center, member of Noble Scientific Advisory Board
  • Dr. Lauren Wood, Chief Medical Officer at PDS Biotechnology, former Clinical Director of the Vaccine Branch
  • Dr. Johannes Vieweg, Founding Dean and Chief Academic Officer at Nova Southeastern University
  • Dr. Herman Chao, CEO, Helix Biopharma
  • Dr. Mark Erlander – Chief Scientific Officer of Trovagene
  • Dr. John A. Scarlett – Chairman and CEO of Geron Corp
  • Cosme Ordonez, MD, PhD, (Moderator) Noble Capital Markets, Director of Life Sciences Research

Cannabis Stocks: Back Down To Reality? What Investors Should Know About Cannabis Stocks In 2020

Posted on by Admin

Cannabis Stocks: Back down to reality? What Investors Should Know About Cannabis Stocks In 2020

There’s something that investors in the cannabis industry can’t ignore the trends. There is a trend toward removing legal barriers on both a state and local level. There is a trend toward more research dollars and permissions to study its medicinal qualities. The trend of medical legalization on a state-by-state basis. The trend for legal recreational use. There is a trend toward more foreign investment flowing to the cannabis industry. A trend toward reduced stigma for those that choose marijuana as their drug of choice. The trends all seem to add to one natural result. There is enormous opportunity for investors in an industry that is growing in every category. This panel will discuss the most important trends for investors in the industry.

  • Arby Barroso, Co-founder at Green Roads World
  • Brett Finkelstein, Managing Director at Phyto Partners, LP
  • Jason Spatafora, Owner at MarijuanaStocks.com
  • Matt Ginder, Partner at Greenspoon Marder, LLP
  • Roman Bond, Founder at The Leafy Group
  • Jonathan Conforti, VP of Corporate Development at Abacus Health Products, Inc.
  • Robert Friedman (Moderator), Founder at Cannabis Labs

Research great lakes dredge dock gldd profitability remains high and 2020 outlook robust

Posted on by Admin

Thursday, February 20, 2020

Great Lakes Dredge & Dock (GLDD)

Profitability Remains High and 2020 Outlook Robust

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The company only’s operating segments is Dredging. Dredging involves the enhancement or preservation of navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand or rock. Its projects portfolio includes Coastal Restoration, Coastal Protection, Port expansion, and others.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Strong execution and higher profitability more than offset lower revenues. While total revenue of $164.3 million was lower than expected by ~$25 million, gross profit of $34.6 million was in line with our estimate, and gross margin improved to 21%, which was above our estimate of 19.0%.

No change to 2020 EBITDA estimate. We’ll further fine-tune our 2020 estimate of $140.3 million, up from 2019 EBITDA of $135.6 million, and introduce a…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

IMO2020: Major Shift in Fuel Regulations

Posted on by Admin

IMO2020: Major Shift in Fuel Regulations

At the beginning of 2019, IMO2020 required shipping companies to comply with new regulations designed to improve air emissions by lowering the sulfur emitted in flue gases. Panelists will detail their views on the low sulfur requirement and its impact on shipping. Some companies have shifted to compliant low sulfur fuel while others are investing in equipment to remove sulfur. Attendees will come to understand how decisions are made, how what is best for one company may not suit another, and what is coming down the road.

  • Gary Vogel, CEO Eagle Bulk Shipping, Inc.
  • Jeffrey D. Pribor, CFO, Treasurer, International Seaways, Inc.
  • Eddie Valentis (Pyxis Tankers) CEO
  • Tasos Aslidis, CFO (EuroDry and Euroseas)
  • Mads Petersen, Managing Director, Nordic Bulk Carriers
  • Stamatios Tsantanis, CEO Seanergy Maritime Holdings
  • Poe Fratt (Moderator) – Senior Transportation & Logistics Analyst at Noble Capital Markets

Type 1 Diabetes: A Functional Cure Could Be Imminent

Posted on by Admin

Type 1 Diabetes: A Functional Cure Could Be Imminent
Tuesday, February 18 – 10:00am – 11:00am – Terrace Ballroom B

A medical cure, not an improved treatment, for T1D, will be the discussion by leading medical researchers in the field. Accelerated advancements that began by an unplanned meeting by two of our panelists during NobleCon14 hatched an idea that is now leading to promising clinical study results. The panel will also include a famous advocate and T1D sufferer, who is elevating the voice of those with diabetes with his national podcast. The novel approach toward a cure and clinical study results will be central to the presentation.

  • Dr. Camillo Ricordi, Director of the Diabetes Research Institute at the University of Miami School of Medicine
  • Dr. Matthias von Herrah, MD, Founder of the Type 1 Diabetes Center at La Jolla Institute for Immunology
  • Dr. Bastiano Sanna, President, and COO of Semma Therapeutics
  • Dr. Steven Perrin, CEO, and co-Founder of Anelixis Therapeutics.
  • Eric Paslay, Platinum-selling songwriter/performer, Owner of Apple Podcast Level With Me
  • Nathan Cali, Managing Director, Head of Healthcare Investment and Merchant Banking at Noble Capital Markets

Research – 1-800-Flowers.com (FLWS) – Gets Into A Personal Space

Posted on by Admin

Thursday, February 20, 2020

1-800-Flowers.com (FLWS)

Gets Into A Personal Space

1-800-FLOWERS.COM, Inc. is the leading provider of gourmet and floral gifts for all occasions. For nearly 40 years, 1-800-FLOWERS® has been helping deliver smiles for customers with gifts for every occasion, including fresh flowers, premium, gift-quality fruits, and other gourmet items from Harry & David®, popcorn and specialty treats from The Popcorn Factory®; cookies and baked gifts from Cheryl’s®; premium chocolates and confections from Fannie May®; gift baskets and towers from 1-800-Baskets.com®; premium English muffins and other breakfast treats from Wolferman’s; carved fresh fruit arrangements from FruitBouquets.com; and top quality steaks and chops from Stock Yards®. The Company’s BloomNet® international floral wire service provides a broad range of quality products and value-added services designed to help professional florists grow their businesses profitably.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Adds A Personal Touch. The company announces plans to purchase PersonalizationMall.com from Bed, Bath & Beyond for $242 million. The transaction is expected to close in early April, 2020. We view the acquisition favorably as it expands its everyday gifting platform, further distances itself from its peers that a narrow gifting offering.

Reasonable purchase price. The purchase price is estimated to be 1.7 times trailing revenues and 10 times estimated fiscal 2021 EBITDA. a fair price for a business growing revenues in the high-single digit to low-double digits and for cash flow margins in the 15% range. Tax benefits bring the purchase price to…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Noble Capital Markets 2020 Investor Conference – a Huge Success

Posted on by Admin

High Marks Across the Board Given to NobleCon16

If the success of an investment conference is measured by effective use of time, key participants, organization, and significant opportunities to perhaps act upon, then NobleCon16 (Noble Capital Markets, 16th small and microcap investor conference) was a tremendous  success. This was the first ever event of this magnitude at the new Hard Rock, Guitar Hotel, in South Florida.  They also received high marks as they served the host and attendees flawlessly.  The pace of smart money dicovering brilliant ideas was never interrupted over the two days.

From early morning, every half hour, company presentations were held in each of four meeting rooms during the two full days. Interested investors visited these meeting rooms to collect knowledge and understanding of the companies presenting, and to have their questions answered.  As the audience inquiries often went a bit beyond the allotted time, the presenters would continue to engage the companies in the massive halls of the conference facility. During the presentations, two other massive salons were buzzing with tables where investors met with companies in a personal one-on-one setting.  These meetings ran non-stop through Monday and Tuesday as well.

In addition to the investor/company meetings and presentations, NobleCon16 featured two “in-the-know” keynote speakers invited to share their thoughts on topics pertinent to everyone interested in business today. Jeb Bush lead off on Monday, Presidents Day, with his take on the current political climate and sharing his hope of “civility” coming back to national politics.  On Tuesday, Ari Fleischer treated a packed ballroom to his stories as White House Press Secretary, and how the news media has changed since then.  Both addresses concluded with standing ovations. The audience was left with insights they may not have received from anyplace other than NobleCon.

There was some play-time to be had as well. Conference attendees had the Hard Rock’s Daer Night Club all to themselves. One conference presenter, recording-artist Eric Pasley, took the stage and treated everyone at this private event to a few songs. The next morning Pasley took a much different stage beside some of the world’s top scientists demonstrating that they are getting close to a functional cure for diabetes.  

While the  Noble Capital Markets investor conference has come to a close, the coming days and months will find many attendees back at their offices and homes analyzing a bit deeper and making decisions on opportunities presented. For those that were fortunate enough to attend or even those who were not, the presentations from the event can be found on Channelchek in the lower-left corner of your screen.

Cannabis Panel From NobleCon16 – Cannabis Stocks: Back Down To Reality? What Investors Should Know About Cannabis Stocks In 2020

Posted on by Admin

Cannabis Stocks: Back down to reality? What Investors Should Know About Cannabis Stocks In 2020

There’s something that investors in the cannabis industry can’t ignore the trends. There is a trend toward removing legal barriers on both a state and local level. There is a trend toward more research dollars and permissions to study its medicinal qualities. The trend of medical legalization on a state-by-state basis. The trend for legal recreational use. There is a trend toward more foreign investment flowing to the cannabis industry. A trend toward reduced stigma for those that choose marijuana as their drug of choice. The trends all seem to add to one natural result. There is enormous opportunity for investors in an industry that is growing in every category. This panel will discuss the most important trends for investors in the industry.

  • Arby Barroso, Co-founder at Green Roads World
  • Brett Finkelstein, Managing Director at Phyto Partners, LP
  • Jason Spatafora, Owner at MarijuanaStocks.com
  • Matt Ginder, Partner at Greenspoon Marder, LLP
  • Roman Bond, Founder at The Leafy Group
  • Jonathan Conforti, VP of Corporate Development at Abacus Health Products, Inc.
  • Robert Friedman (Moderator), Founder at Cannabis Labs

Transportation Panel From NobleCon16 – IMO2020: Major Shift in Fuel Regulations

Posted on by Admin

IMO2020: Major Shift in Fuel Regulations

At the beginning of 2019, IMO2020 required shipping companies to comply with new regulations designed to improve air emissions by lowering the sulfur emitted in flue gases. Panelists will detail their views on the low sulfur requirement and its impact on shipping. Some companies have shifted to compliant low sulfur fuel while others are investing in equipment to remove sulfur. Attendees will come to understand how decisions are made, how what is best for one company may not suit another, and what is coming down the road.

  • Gary Vogel, CEO Eagle Bulk Shipping, Inc.
  • Jeffrey D. Pribor, CFO, Treasurer, International Seaways, Inc.
  • Eddie Valentis (Pyxis Tankers) CEO
  • Tasos Aslidis, CFO (EuroDry and Euroseas)
  • Mads Petersen, Managing Director, Nordic Bulk Carriers
  • Stamatios Tsantanis, CEO Seanergy Maritime Holdings
  • Poe Fratt (Moderator) – Senior Transportation & Logistics Analyst at Noble Capital Markets

Cancer Panel From NobleCon16 – Cancer Treatment: Tackling the Disease Through Innovative Strategies

Posted on by Admin

Cancer Treatment: Tackling the Disease Through Innovative Strategies

Current revolutionary new strategies to defeat cancer will be discussed by experts at the forefront of cancer research and treatment. The medical researchers and academic will probe into the most advanced new technologies aimed at overcoming cancer including innate immunity, modulation of tumor micro-environment, treatment of solid tumors with CAR-T, cancer vaccines and cell cycle inhibitors.

  • Dr. James Mule, Associate Center Director at Moffitt Cancer Center, member of Noble Scientific Advisory Board
  • Dr. Lauren Wood, Chief Medical Officer at PDS Biotechnology, former Clinical Director of the Vaccine Branch
  • Dr. Johannes Vieweg, Founding Dean and Chief Academic Officer at Nova Southeastern University
  • Dr. Herman Chao, CEO, Helix Biopharma
  • Dr. Mark Erlander – Chief Scientific Officer of Trovagene
  • Dr. John A. Scarlett – Chairman and CEO of Geron Corp
  • Cosme Ordonez, MD, PhD, (Moderator) Noble Capital Markets, Director of Life Sciences Research

Mining Panel From NobleCon16 – Creating Shareholder Value in the Mining Sector: What is the Recipe?

Posted on by Admin

Creating Shareholder Value in the Mining Sector: What is the Recipe?

Differentiation between mining companies and understanding what efforts have paid off better than others is a big part of understanding shareholder value. There will be a look at the Fraser ranking of mining jurisdictions and recent movement of companies within the rankings and where they operate. Discussions will also center on who is moving up, moving down, and thoughts from the panel regarding the survey and the jurisdictions where they operate. The panelists will answer the questions: Should investors focus more on financial returns or production growth?

  • Trey Wasser, President, CEO, and Director, Ely Gold Royalties Inc.
  • Scott Hicks, Lumina Gold Corp., VP, Corporate Development and Communications
  • Robert Archer, CEO, and Director, Newrange Gold Corp.
  • Igor Gonzales, CEO, and President, Sierra Metals
  • Greg Crowe, CEO, and President, Silver One Resources
  • Dale Mah, VP Corporate Development Endeavour Silver
  • Mark Reichman, (Moderator) Senior Research Analyst, Noble Capital Markets

Inflammasomes Panel From NobleCon16 – Inflammasome Inhibitors: The Next Generation of Innovative Immunotherapy Agents

Posted on by Admin

Inflammasome Inhibitors: The Next Generation of Innovative Immunotherapy Agents

Recent breakthroughs in regulating inflammasomes will be discussed by experts on the leading edge of new discovery and therapies. Inflammatory disorders, including Alzheimer’s, inflammatory bowel disease, multiple sclerosis, Crohn’s, non-alcoholic fatty liver disease, chronic kidney disease, lupus, diabetes, and cancer, affect 5-7% of Western populations. The companies represented on this panel could potentially translate current research into future treatments.

  • Paul Ashton, PhD., Co-Founder & CEO of Inflammasome Therapeutics, Inc.
  • Gary Glick, PhD., Co-Founder & Executive Chairman of IFM Therapeutics and Michigan Professor of Chemistry
  • Steve Glover, Co-Founder, President & CEO of Zyversa Therapeutics, Inc.
  • Robert W. Keane, PhD., Professor Physiology & Biophysics, Neurological Surgery & Microbiology, and Immunology at the University of Miami, and co-founder of InflamaCore, LLC

  • Clay B. Thorp, General Partner at Hatteras Venture Partners

Diabetes Panel From NobleCon16 – Type 1 Diabetes: A Functional Cure Could Be Imminent

Posted on by Admin

Type 1 Diabetes: A Functional Cure Could Be Imminent
Tuesday, February 18 – 10:00am – 11:00am – Terrace Ballroom B

A medical cure, not an improved treatment, for T1D, will be the discussion by leading medical researchers in the field. Accelerated advancements that began by an unplanned meeting by two of our panelists during NobleCon14 hatched an idea that is now leading to promising clinical study results. The panel will also include a famous advocate and T1D sufferer, who is elevating the voice of those with diabetes with his national podcast. The novel approach toward a cure and clinical study results will be central to the presentation.

  • Dr. Camillo Ricordi, Director of the Diabetes Research Institute at the University of Miami School of Medicine
  • Dr. Matthias von Herrah, MD, Founder of the Type 1 Diabetes Center at La Jolla Institute for Immunology
  • Dr. Bastiano Sanna, President, and COO of Semma Therapeutics
  • Dr. Steven Perrin, CEO, and co-Founder of Anelixis Therapeutics.
  • Eric Paslay, Platinum-selling songwriter/performer, Owner of Apple Podcast Level With Me
  • Nathan Cali, Managing Director, Head of Healthcare Investment and Merchant Banking at Noble Capital Markets